Gossamer Bio
Price & Volume
Stats
See moreOpen | $0.20 |
Previous Close | $0.20 |
Day Range | $0.17-$0.20 |
52W Range | $0.11-$3.87 |
Market Cap | $99.9M |
Shares Short | 94M |
Financials
See moreRevenue (12 Mos) | $53.2M |
Revenue Growth (YoY) | -19.6% |
Gross Profit (12 Mos) | $53.2M |
Diluted EPS | -$0.77 |
News
See moreYahoo Finance • 3 days ago
Gossamer Bio announces $250m in funding to advance seralutinib
Yahoo Finance • 5 days ago
Sector Update: Healthcare Stocks Advance in Afternoon Trading
Yahoo Finance • 30 days ago
Top Biotech Gainers: GOSS To File Seralutinib NDA In Sep, OMER Gains On AZN's Loss, FBRX Acquired
Yahoo Finance • 30 days ago
Gossamer Sets September NDA Filing For Seralutinib In Pulmonary Arterial Hypertension; Stock Up
About
CEO | Mr. Faheem Hasnain |
CFO | Mr. Bryan Giraudo |
Address | 3115 Merryfield Row, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 161 |